Adjusting Injectable Contraceptive Use for Months Since the Last Injection.
Malawi
contraception
injectables
Journal
Studies in family planning
ISSN: 1728-4465
Titre abrégé: Stud Fam Plann
Pays: United States
ID NLM: 7810364
Informations de publication
Date de publication:
04 Feb 2024
04 Feb 2024
Historique:
medline:
4
2
2024
pubmed:
4
2
2024
entrez:
4
2
2024
Statut:
aheadofprint
Résumé
Injectables are one of the most popular methods of contraception worldwide, particularly in sub-Saharan Africa. An advantage of injectables over shorter-acting methods is that they provide additional flexibility by not requiring re-supply as frequently. However, there is a risk that injectable users may delay their next injection and may therefore have reduced or no protection from pregnancy. In surveys, women may report that they are using contraception in the form of injectables when the time since they had their last injection (more than four months) would imply that they have reduced protection against the risk of pregnancy. We carried out two field studies in urban Malawi, and we record reported injectable contraceptive use while also asking the number of months since women received their last injection. We observe that 13.8 percent of women who report using injectables also report that they received their last injection more than four months ago, and 11 percent report that they received their last injection more than six months ago. Our analysis highlights the need for additional follow-up with women who report using injectables in surveys to confirm whether they are, in fact, using the method effectively.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : College of Arts and Sciences, Boston University Global Development Policy Center
Organisme : William and Flora Hewlett Foundation
Organisme : 2014-9952, 2017-5795, 2020-1162
Informations de copyright
© 2024 The Authors. Studies in Family Planning published by Wiley Periodicals LLC on behalf of Population Council.
Références
Aho, J., A. Koushik, S. L. Diakité, K. M. Loua, V. K. Nguyen, and S. Rashed. 2010. “Biological Validation of Self-Reported Condom Use Among Sex Workers in Guinea.” AIDS and Behavior 14 (6): 1287-1293.
Bertrand, J. T., J. Ross, T. M. Sullivan, K. Hardee, and J. D. Shelton. 2020. “Contraceptive Method Mix: Updates and Implications.” Global Health: Science and Practice 8(4): 666-679.
Garza-Flores, J., S. Cardenas, V. Rodríguez, M. C. Cravioto, V. Diaz-Sanchez, and G. Perez-Palacios. 1985. “Return to Ovulation Following the Use of Long-Acting Injectable Contraceptives: A Comparative Study.” Contraception 31(4): 361-366.
Gemmill, A., S. E. K. Bradley, B. O. Berger, and S. O. Bell. 2023. “The Relationship Between Contraceptive Method Use and Return of Fecundity Among Women Attempting Pregnancy in Low- and Middle-Income Countries.” Demography 60(4): 1163-1179.
Halpern, V., V. Brache, D. Taylor, A. Lendvay, L. Cochón, J. T. Jensen, and J. Dorflinger. 2021. “Clinical Trial to Evaluate Pharmacokinetics and Pharmacodynamics of Medroxyprogesterone Acetate After Subcutaneous Administration of Depo-Provera.” Fertility and Sterility 115(4): 1035-1043.
ICF International. 2017. “The DHS Program: Demographic and Health Surveys.” http://dhsprogram.com/
Karra, M., and D. Canning. 2020. “The Effect of Improved Access to Family Planning on Postpartum Women: Protocol for a Randomized Controlled Trial.” JMIR Research Protocols 9(8): e16697.
Karra, M., and K. Zhang. 2021. “User-Centered Counseling and Male Involvement in Contraceptive Decision Making: Protocol for a Randomized Controlled Trial.” JMIR Research Protocols 10(4): e24884.
Kaunitz, A. M. 2000. “Injectable Contraception: New and Existing Options.” Obstetrics and Gynecology Clinics of North America 27(4): 741-780.
Khan, S., B. Grady, and S. Tifft. 2015. “Estimating Demand for a New Contraceptive Method: Projections for the Introduction of Sayana Press.” International Journal of Gynecology & Obstetrics 130(S3): E21-E24.
Mansour, D., K. Gemzell-Danielsson, P. Inki, and J. T. Jensen. 2011. “Fertility After Discontinuation of Contraception: A Comprehensive Review of the Literature.” Contraception 84(5): 465-477.
Nelson, H. N., S. Borrero, E. Lehman, D. L. Velott, and C. H. Chuang. 2017. “Measuring Oral Contraceptive Adherence Using Self-Report Versus Pharmacy Claims Data.” Contraception 96(6): 453-459.
Pardthaisong, T.. 1984. “Return of Fertility After Use of the Injectable Contraceptive Depo Provera: Up-Dated Data Analysis.” Journal of Biosocial Science 16(1): 23-34.
Pyra, M., J. R. Lingappa, R. Heffron, D. W. Erikson, S. W. Blue, R. C. Patel, K. Nanda, H. Rees, N. R. Mugo, N. L. Davis, A. P. Kourtis, and J. M. Baeten. 2018. “Concordance of Self-Reported Hormonal Contraceptive Use and Presence of Exogenous Hormones in Serum Among African Women.” Contraception 97(4): 357-362.
Taylor, D. J., V. Halpern, V. Brache, L. Bahamondes, J. T. Jensen, and L. J. Dorflinger. 2022. “Ovulation Suppression Following Subcutaneous Administration of Depot Medroxyprogesterone Acetate.” Contraception: X 4: 100073.
Westhoff, C.. 2003. “Depot-medroxyprogesterone Acetate Injection (Depo-Provera®): A Highly Effective Contraceptive Option with Proven Long-Term Safety.” Contraception 68(2): 75-87.
World Health Organization. 1997. “Injectable Contraceptives: What Health Workers Need to Know.” Report No.: WHO/FRH/FPP/97.31, World Health Organization, Geneva, Switzerland.
World Health Organization. 2016. Selected Practice Recommendations for Contraceptive Use. Geneva, Switzerland: World Health Organization.